INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
BENYLIN WET COUGH MENTHOL

SCHEDULING STATUS:
S0

PROPRIETARY NAME
(and dosage form):

BENYLIN WET COUGH MENTHOL
(Syrup)

COMPOSITION:
Quantity per 10 mL:

	Guaifenesin	200 mg
	Alcohol	9,5% v/v
	Preservative:
	Sodium Benzoate	0,2% m/v

PHARMACOLOGICAL CLASSIFICATION:
A: 10.1 Antitussives and Expectorants.

PHARMACOLOGICAL ACTION:
Guaifenesin has expectorant properties.

INDICATIONS:
Alleviation of cough.

CONTRA-INDICATIONS:
Allergy to any of the ingredients. Pregnancy and lactation.
Guaifenesin is considered unsafe in patients with acute porphyria.

DOSAGE AND DIRECTIONS FOR USE:
Adults:         10 mL - 20 mL (two - four medicine measures) every 4 hours.
If symptoms persist a doctor should be consulted.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Gastro-intestinal discomfort and drowsiness may occur.
Guaifenesin may interfere with diagnostic measurements of urinary 5-hydroxy-indoleacetic acid or vanillylmandelic acid.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
In large doses, Guaifenesin will cause drowsiness, nausea and vomiting.
Treatment is symptomatic and supportive.

IDENTIFICATION:
A reddish-brown, syrupy liquid with a strong peppermint-caramel odour and taste.

PRESENTATION:
Bottles of 50 mL and 100 mL.

STORAGE INSTRUCTIONS:
Store in a cool place (below 25°C). KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
28/10.1/0374

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pfizer Consumer Healthcare, division of
Warner-Lambert S.A. (Pty) Ltd.
241 Main Road
RETREAT
7945

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
30 March 1994

EXPORT REGISTRATION DETAILS Zambia:        082/039

Revised: JUN99; NOV98

Updated on this site: January 2005
Source: Pharmaceutical Industry
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2005